infiltration and hilar lymphadenopathy with which they are associated can lead to a mistaken diagnosis of The pathophysiology of the sulphasalazineinduced eosinophilic pneumonia is unknown,' but prognosis is generally good after discontinuation of the drug.4 The prognosis of fibrosing alveolitis is less good and steroids are often needed to achieve healing.
Sulphasalazine is a commonly used drug that is rarely associated with pulmonary damage, which may be confused with underlying pulmonary disease due to rheumatoid arthritis. The possibility of drug-induced pulmonary disease should be considered in any patient receiving sulphasalazine showing symptoms and radiographic evidence of pulmonary disease.
